Utitropin 100 IU Utinon

Description

Utitropin 100 IU Utinon — recombinant human growth hormone from Utinon at 100 IU. Cold-chain pharmaceutical requiring 2–8°C storage pre-reconstitution. IGF-1 elevation persists 20–24 hours; once-daily subcutaneous dosing is effective.

Key Benefits

• Recombinant 191-amino-acid sequence — identical to pituitary HGH
• Mobilises visceral fat, improves recovery, thickens connective tissue
• Long-game compound — 3–6 month commitment minimum
• Does not suppress HPTA, does not aromatise
• Cold-chain storage after reconstitution; lyophilised vial stable at 2–8 °C
• Each unit dosed at 100 IU — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: fat-loss / recovery 2–3 IU/day SubQ AM; bodybuilding 4–6 IU/day; anti-aging 1–2 IU/day. Morning dosing on empty stomach maximises lipolytic window. Cycles 3–6 months minimum — effects are cumulative, not acute.

How It Works

Recombinant growth hormone (somatotropin), 191-amino-acid single-chain polypeptide produced via E. coli expression. Binds pituitary-axis-independent GH receptors; liver converts to IGF-1 (primary mediator of growth effects). Drives lipolysis, collagen synthesis, and satellite-cell recruitment.

Pharmacokinetics

HGH plasma half-life ~2–3 hours; IGF-1 signalling downstream persists 12–16 hours — hence once-daily dosing produces clinical effect despite short serum residency. Reconstituted vial stable 2–8 °C for 14 days.

Potential Side Effects

Dose-dependent: 1–3 IU/day well-tolerated; 4 IU+/day water retention, carpal-tunnel symptoms, insulin resistance risk. Fasting glucose monitoring quarterly on extended runs. HbA1c at month 3. Insulin resistance the main long-run concern above 4 IU.

Cycle & Stacking Guide

3–6 month protocols. Stacks cleanly with TRT, blasts, and peptide secretagogues. Target IGF-1 on 2.5 IU/day: 250–350 ng/mL. Pull IGF-1 at week 8 to verify product activity — if still baseline (~150 ng/mL), either dose too low or product underdosed.

Manufacturer Notes

IU Utinon is an Iranian GMP producer with decades of domestic pharmaceutical experience. The catalogue features both injectable and oral formats.

Storage & Handling

Pre-reconstitution: store at 2–8 °C, protected from freezing and light. Post-reconstitution: use within 14–21 days, maintained at 2–8 °C throughout. Never freeze reconstituted solution — freezing irreversibly denatures the protein. Transport in an insulated cold-pack for trips. Keep out of reach of children. For research and educational purposes only.